SSE: 2185 - Shanghai Bio-heart Biological Technology Co., Ltd.

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Reporting Shanghai Bio-heart Biological Technology Co., Ltd.

Capitalization

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Капитализация, млрд ¥
1.01
Чистая прибыль, млрд ¥
-0.2042
EV, млрд ¥
0.5384
EBITDA, млрд ¥
-0.2373


Balance sheet

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Наличность, млрд ¥
0.4513
Долг, млрд ¥
0.0181


Share

IFRS
Reporting Annual
LTM 5 year average CAGR 5
EPS -0.89


Efficiency

IFRS
Reporting Annual
2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % -23.68 7.85
ROA, % -15.04 4.30
ROS, % 0 0 0 0 8.11
ROCE, % 0 0 0.00
Ebit margin, % 0 0
Рентаб EBITDA, % 0 0 -351.29
Чистая рентаб, % 0 8.10
Operation Margin, % 0 0 0 0 4.29


Coefficients

IFRS
Reporting Annual
2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/BV
1.05 3.67
P/FCF
0 0 0 0 7.85
E/P
-0.2022 -0.2022 -0.2022 -0.2022 0.03
EV/EBITDA
-2.58 19.30
EV/EBIT
0 0 0
EV/S
0 0 0 0 59.91
EV/FCF
0 0 0 4.07
Debt/EBITDA
-0.0763 -0.0763 -0.0763 -0.0763 1.91
Netdebt/Ebitda
0 0 0 0 0.24
Debt/Ratio
0 0 0 0 0.07
Debt/Equity
0 0 0 0 0.14
Debt/Net Income
-0.0886 -0.0886 -0.0886 -0.0886 3.99
Бета
0 0 0 0 0.13
Индекс Альтмана
0 0 0 0 7.02


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденды / прибыль, %
0 41.32


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 2024 CAGR 5
Персонал, чел
54 58